HomeKYTX • NASDAQ
add
Kyverna Therapeutics Inc
Previous close
$8.63
Day range
$8.60 - $9.30
Year range
$1.78 - $13.67
Market cap
530.06M USD
Avg Volume
625.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.27M | 22.63% |
Net income | -37.80M | -0.84% |
Net profit margin | — | — |
Earnings per share | -0.80 | 9.09% |
EBITDA | -38.91M | 3.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 279.25M | -2.35% |
Total assets | 293.83M | -3.55% |
Total liabilities | 61.55M | 61.73% |
Total equity | 232.28M | — |
Shares outstanding | 60.46M | — |
Price to book | 2.24 | — |
Return on assets | -40.84% | — |
Return on capital | -46.96% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -37.80M | -0.84% |
Cash from operations | -33.53M | 9.54% |
Cash from investing | -17.29M | -159.16% |
Cash from financing | 140.74M | 65,561.86% |
Net change in cash | 89.93M | 1,216.58% |
Free cash flow | -19.88M | 10.98% |
About
Founded
2018
Headquarters
Website
Employees
134
